|
DVL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.12559999987383E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.42709996545187E-09 |
| Normal-vs-Stage2 |
2.796100E-02 |
| Normal-vs-Stage3 |
2.328500E-02 |
| Normal-vs-Stage4 |
3.621300E-03 |
| Stage1-vs-Stage2 |
1.259960E-01 |
| Stage1-vs-Stage3 |
4.818100E-02 |
| Stage1-vs-Stage4 |
1.882760E-01 |
| Stage2-vs-Stage3 |
8.520800E-01 |
| Stage2-vs-Stage4 |
7.533800E-01 |
| Stage3-vs-Stage4 |
5.833800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.63830000005283E-06 |
| Normal-vs-AfricanAmerican |
3.51400000000446E-05 |
| Normal-vs-Asian |
1.292260E-02 |
| Caucasian-vs-AfricanAmerican |
2.146200E-02 |
| Caucasian-vs-Asian |
2.928400E-02 |
| AfricanAmerican-vs-Asian |
6.623800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.7278000000196E-06 |
| Normal-vs-Female |
4.9433000004484E-07 |
| Male-vs-Female |
2.850000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.716300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.47359999985919E-07 |
| Normal-vs-Age(61-80Yrs) |
3.89410000001256E-06 |
| Normal-vs-Age(81-100Yrs) |
9.800800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.600800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.755000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.249370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.536000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.675900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.425800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.94850000000103E-05 |
| Normal-vs-Grade 2 |
3.22550000042554E-08 |
| Normal-vs-Grade 3 |
4.578200E-04 |
| Normal-vs-Grade 4 |
4.339600E-02 |
| Grade 1-vs-Grade 2 |
1.990560E-04 |
| Grade 1-vs-Grade 3 |
7.84700000000527E-05 |
| Grade 1-vs-Grade 4 |
5.370200E-04 |
| Grade 2-vs-Grade 3 |
8.445800E-02 |
| Grade 2-vs-Grade 4 |
1.591760E-01 |
| Grade 3-vs-Grade 4 |
7.553400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.80479999833949E-08 |
| Normal-vs-ccB subtype |
7.456000E-03 |
| ccA subtype-vs-ccB subtype |
8.242300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.82390000000155E-05 |
| Normal-vs-N1 |
1.038410E-01 |
| N0-vs-N1 |
4.773600E-01 |
|
|
